Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic correspondence

Executive Summary

FDA Office of Generic Drugs requests that all ANDAs, AADAs, amendments and supplements mailed to the agency via the U.S. Postal Service be addressed to: Office of Generic Drugs, CDER, FDA, MPN II, HFD-600, 5600 Fishers Lane, Rockville, MD, 20857. Correspondence not associated with an application should be sent to the same address with the division, person and appropriate HFD- code specified. Only parcel post or overnight courier service should be addressed to: Office of Generic Drugs, CDER, FDA, Metro Park North II, 7500 Standish Pl., Room 150, Rockville, MD, 20855.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS018762

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel